Delivery Order SPE2DE21D0005-SPE2D625F2V2P

Award Date 4/14/25
Potential Completion Date 4/17/25
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,239.95 fixed-price contract with economic price adjustment is for the delivery of APLIGRAF, a skin substitute product. Organogenesis, a for-profit manufacturer, has an established track record of supplying specialized medical supplies, including wound care and tissue regeneration solutions, to the...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medical products based in Canton, Massachusetts. The contract is a delivery order for the APLIGRAF skin substitute product, with a period of performance through May 1, 2025. This award is not associated with a set-aside designation, indicating Organogenesis competes as a standard commercial vendor....
This is a federal contract award from the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The award, valued at $1,239.95, is for the delivery of APLIGRAF, a skin substitute product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) vehicle held by Organogenesis with the DLA, valued at $49.5 million, for wound care dressings and medical supplies. This IDC was awarded as a total small...
This federal contract award to Organogenesis Inc., a leading regenerative medicine company, is for the delivery of APLIGRAF, a wound care product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,239.95 fixed-price delivery order, which includes an economic price adjustment, has a completion date of June 11, 2024. Organogenesis Inc. is a for-profit manufacturer of goods and has been a registered federal contractor since 2006. The company holds several significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract is for the supply of the company's APLIGRAF product, a specialized skin substitute used in medical treatments. The $1,239.95 fixed-price contract with economic price adjustment has a completion date of November 13, 2024....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer of regenerative medical products. The $1,239.95 fixed-price contract with economic price adjustment is for the delivery of APLIGRAF, a skin substitute product. The contract has an ultimate completion date of March 10, 2025. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,479.90 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, to provide APLIGRAF, a specialized skin substitute and wound matrix product. The contract has a period of performance through November 25, 2024 and utilizes a Fixed Price with Economic Price Adjustment pricing structure. Organogenesis is a for-profit manufacturer that has been awarded numerous federal contracts to supply a range...
This federal contract award, valued at $3,719.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is a delivery order for the medical product APLIGRAF, a skin substitute. This award is part of Organogenesis' larger federal contract vehicles, including a $25 million Indefinite Delivery Contract with the Department of Veterans Affairs (VA) for surgical implants, a $30 million...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,239.95 Delivery Order (SPE2DE21D0005|SPE2D625F228P) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is for the delivery of the advanced wound care product APLIGRAF. The order is a Fixed Price with Economic Price Adjustment contract with a completion date of November 1, 2024. Organogenesis, headquartered in Canton, Massachusetts, is a key supplier of medical products to federal...
This federal contract award is for a delivery order (SPE2DE21D0005|SPE2D625F52FT) with a ceiling value of $1,239.95, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit medical manufacturer headquartered in Canton, Massachusetts. The contract is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration needs across military and veteran healthcare systems. Organogenesis holds several...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F2V2P
    Delivery Order

This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of APLIGRAF, a skin substitute product. The contract is a Delivery Order, with a Ceiling Value of $1,239.95, and a Fixed Price with Economic Price Adjustment pricing type. The contract has an Ultimate Completion Date of April 17, 2025. Organogenesis Inc. is a for-profit manufacturer and has been a key supplier of medical products to federal healthcare agencies, primarily the Department of Veterans Affairs (VA) and the DLA, focusing on advanced wound care, surgical biologics, and tissue regeneration products. This contract award is not associated with a set-aside designation, indicating Organogenesis competes as a standard commercial vendor. The contract supports wound healing and tissue regeneration treatments for military personnel and veterans across the VA and DLA medical systems.

Generated 7/14/25, 11:02 AM